GlassScriptPhysician profile
Barnaby Frederick Starr
NPI 1255433595
$2,020.88
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $753 · 2021: $416 · 2022: $59.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $865.89 | 2019-2021 | |
| Tris Pharma INC | $259.31 | 2019-2021 | |
| Cranial Technologies, INC | $189.53 | 2019-2022 | |
| Adlon Therapeutics L.P. | $112.53 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $100.69 | 2019-2022 | |
| Shire North American Group INC | $93.87 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.96 | 2020-2021 | |
| Glaxosmithkline, LLC. | $72.08 | 2019-2022 | |
| Pfizer INC. | $69.90 | 2019 | |
| Merck Sharp & Dohme LLC | $56.67 | 2019-2020 | |
| Sanofi Pasteur INC. | $35.38 | 2019-2021 | |
| Sobi, INC | $32.65 | 2020 | |
| Biogen, INC. | $16.88 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.85 | 2019 | |
| Kaleo, INC. | $13.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barnaby Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.